The following article on Anxiety Disorders is from the National Institute of Mental Health (NIMH). While this material has been expert-reviewed, it is not NIMH or MHANYS intention to provide specific medical advice. Both MHANYS and NIMH advise readers to consult with a qualified health care provider for diagnosis, treatment, and answers to personal questions.

What are brain stimulation therapies?

Brain stimulation therapies can play an important role in treating mental disorders. These therapies act by activating or inhibiting the brain with electricity. The electricity can be given directly through electrodes implanted in the brain or indirectly through electrodes placed on the scalp. The electricity can also be induced by applying magnetic fields to the head.

This video from the National Institute of Mental Health (NIMH) provides an overview of brain stimulation therapies and how they can be used to treat mental disorders.

This page provides basic information about brain stimulation therapies. It does not cover all forms of therapy or all mental disorders for which a therapy might be used. The information should not be used as a guide for making medical decisions. Research is ongoing to determine the best use of these therapies and if they are effective treatments for other disorders and conditions.

The page is divided into therapies that are authorized by the U.S. Food and Drug Administration (FDA) to treat specific mental disorders, including depression, bipolar disorder, and obsessive-compulsive disorder (OCD), versus therapies that are newer and still considered experimental.

The authorized therapies covered on this page are:

• Electroconvulsive therapy
• Repetitive transcranial magnetic stimulation
• Vagus nerve stimulation

The experimental therapies covered on this page are:

• Magnetic seizure therapy
• Deep brain stimulation

Other brain stimulation therapies not discussed here may also hold promise for treating mental disorders. Information about these therapies is updated frequently. See the FDA website  for the latest information, warnings, and guidance on brain stimulation devices and announcements about new ones.

How do brain stimulation therapies work?

In most cases, brain stimulation therapy is used only after other treatments have been tried. Although brain stimulation therapies are less frequently used than medication or psychotherapy, they hold promise for people with certain mental disorders who have not responded to other treatments.

Brain stimulation therapies should be prescribed and monitored by a health care provider with specific training and expertise. A trained medical team performs the therapies. Most of the therapies involve using anesthesia to sedate the patient and a muscle relaxant to prevent them from moving. If so, an anesthesiologist will monitor breathing, heart rate, and blood pressure throughout the procedure.

A treatment plan involving brain stimulation therapy is based on a person’s individual needs and medical situation. It usually also includes medication, psychotherapy, or both. Patients will likely be advised to continue these other treatments during and after therapy to maintain clinical improvement. Patients should not stop a treatment unless specifically advised by a health care provider.

Brain stimulation therapies treat serious mental illnesses. They are often used when a person with a serious mental illness is experiencing dangerous circumstances, such as not responding to the outside world or being at risk of harming themselves. If you or someone you know is struggling or having thoughts of suicide, call or text the 988 Suicide and Crisis Lifeline  at 988 or chat at 988lifeline.org . In life-threatening situations, call 911.

Authorized therapies

The FDA determines whether foods, drugs, medical devices, and other products are safe to use. The FDA commonly gives two types of authorization to devices like brain stimulation therapies.

• Approved means that the FDA has decided that the benefits of the device outweigh the known risks, as demonstrated by the results of clinical testing. Approval is usually required for devices that might have a significant risk of injury or illness, including devices implanted in the body.
• Cleared means that the device is substantially equivalent to a similar device that the FDA has already cleared or approved. Clearance is usually given to lower-risk devices used outside of the body.

What is electroconvulsive therapy?

Electroconvulsive therapy (ECT) is a noninvasive procedure that treats serious mental disorders by using an electric current to induce seizure activity in the brain. It has the longest history of use for depression and is one of the most widely used brain stimulation therapies.

ECT: Why it’s done

The FDA has cleared ECT to treat severe depressive episodes  in people aged 13 years and older with depression or bipolar disorder. In some cases, ECT has also been used to treat schizophrenia, schizoaffective disorder, and mania.

ECT is usually considered only if a person’s illness has not improved after trying other treatments like medication or psychotherapy. To be eligible for ECT, a person must have severe, treatment-resistant depression or require a rapid response due to life-threatening circumstances, such as being unable to move or respond to the outside world (e.g., is catatonic), being suicidal, or being malnourished.

ECT can be effective when medications have not worked, cannot be tolerated, or are undesirable due to physical illness, which is often the case in older adults. ECT also begins working more rapidly than antidepressant medications, usually taking effect within the first week of treatment.

ECT: How it works

Before a doctor performs ECT, the patient is sedated with a short-acting general anesthetic and given an intravenous muscle relaxant to prevent movement.

During the procedure:

• Electrodes are placed at precise locations on the patient’s head.
• An electric current is sent through the electrodes into the brain, causing seizure activity that lasts under a minute. Anesthesia ensures that the patient does not experience pain or feel the electrical pulses. Often, a blood pressure cuff is used on an arm or leg to block the muscle relaxant and allow movement of that limb to confirm that the seizure activity is adequate.
• The patient awakens 5–10 minutes after the procedure ends. They may feel groggy at first as the anesthesia wears off, but after about an hour, they are usually alert and can resume normal activities.

A typical course of ECT is administered three times a week until a patient’s symptoms improve (usually within 6–12 treatments). Frequently, a patient who undergoes ECT also takes antidepressant or mood-stabilizing medication.

Although ECT is effective in treating depressive episodes, follow-up treatment—either antidepressant medication or maintenance ECT —is usually required to sustain clinical improvement and reduce the chances that symptoms return. Maintenance ECT varies depending on the patient’s needs and may range from one session per week to one session every few months.

ECT: Side effects

The most common side effects associated with ECT include the following:

• Headaches
• Upset stomach
• Muscle aches
• Memory loss
• Disorientation or confusion

Some patients may experience memory loss, especially of memories around the time of treatment. Sometimes the memory problems are more severe, but usually they improve over the days and weeks following the end of an ECT course.

Research has found that memory problems are more common  with the traditional form of ECT, known as bilateral ECT, in which electrodes are placed on both sides of the head. In comparison, unilateral ECT involves placing an electrode on only one side of the head, typically the right side, because it is opposite the brain’s learning and memory areas, with another electrode placed on top of the head. Many doctors, patients, and families prefer unilateral ECT because it is less likely to cause memory problems.

Modern ECT devices can deliver electrical signals using brief or ultra-brief pulses. These short pulses are as effective as the traditional form of ECT but are given at a lower dose, helping further reduce cognitive side effects.

What is repetitive transcranial magnetic stimulation?

Repetitive transcranial magnetic stimulation (rTMS) is a noninvasive therapy that uses a magnet to deliver repeated low-intensity pulses to stimulate the brain. The magnetic field it creates is about the same strength as an MRI scan.

rTMS: Why it’s done

Several rTMS devices have been cleared to treat specific mental disorders. The FDA cleared the first rTMS device in 2008 for depression  in people who did not respond to at least one antidepressant medication in the current depressive episode. Although ECT is still considered the “gold standard” for treatment-resistant depression, strong clinical evidence supports the effectiveness of rTMS in reducing depressive symptoms. rTMS is now used to treat moderate-to-severe depression in cases where medications have proven ineffective or intolerable.

Since 2008, rTMS has been cleared to treat several types of depression, including depression with comorbid anxiety and depression with suicidality. In 2018, the FDA also cleared rTMS for severe OCD .

More recently, the FDA cleared a rapid-acting form of rTMS for treatment-resistant depression . Accelerated protocols that act more quickly than standard rTMS show similar effectiveness while shortening treatment length. Thus, patients benefit from receiving an entire course of treatment in much less time and getting relief from their symptoms more rapidly.

Newer forms of rTMS  involving magnetic pulses with other parameters are also under investigation to treat depression, OCD, and other mental disorders.

rTMS: How it works

Rather than electric currents, rTMS uses low-intensity magnetic pulses to stimulate the brain. Unlike ECT, in which stimulation is generalized, in rTMS, magnetic stimulation is targeted to a specific brain site. Also, in contrast to ECT, the procedure does not require anesthesia and can be performed in a clinical or office setting.

A typical rTMS session lasts 30–60 minutes. A typical course of rTMS treatment consists of daily sessions 5 days per week for 4–6 weeks.

Accelerated rTMS protocols  work much faster (within seconds to minutes). In this case, multiple sessions are delivered on a single day, with short breaks in between.

During the procedure:

• An electromagnetic coil is held against the head near an area of the brain thought to be involved in mood regulation, cognitive control, or both. These brain areas include the left prefrontal cortex (for depression) and the dorsomedial prefrontal cortex or anterior cingulate cortex (for OCD). In deep TMS, two coils may be used to deliver more stimulation to the region and target larger structures deep in the brain.
• Short electromagnetic pulses are repeatedly administered through the coil or coils. The patient usually feels a slight knocking or tapping on the head as the pulses are administered.
• The magnetic pulses pass easily through the skull and cause small electric currents that stimulate nerve cells in the targeted brain region.

There is not consensus on the best way to position the coil on the head or deliver the electromagnetic pulses. It has also yet to be determined if rTMS works best when delivered as a single treatment or when combined with medication, psychotherapy, or both. Research is underway to establish the safest and most effective uses of rTMS, the optimal brain sites to target, and the best follow-up approach to sustain clinical improvement.

rTMS: Side effects

Overall, rTMS is safe and well tolerated  by patients. But, like all therapies described here, it can have side effects. These include the following:

• Discomfort at the site on the head where the magnet is placed
• Contraction or tingling of scalp, jaw, or face muscles during the procedure
• Mild headaches or brief lightheadedness
• Dizziness

Using magnetic pulses and targeting a specific brain site results in milder stimulation than in ECT, avoiding most seizure activity. Although it is possible for the procedure to cause seizures, a comprehensive review  found that the risk is rare. Most side effects appear to be mild and short-term when expert guidelines  are followed.

Long-term side effects have not been determined, and more research is needed to establish the long-term safety of rTMS.

What is vagus nerve stimulation?

Vagus nerve stimulation (VNS) is a surgical procedure that involves a device implanted under the skin. The device sends electrical pulses through the left vagus nerve that runs from the brainstem through the neck and down the side of the chest and abdomen. The nerve carries messages from the brain to the body’s major organs, including the heart, lungs, and intestines, and between areas of the brain that control mood, sleep, and other functions.

More recently, this therapy has been simplified by the introduction of noninvasive VNS (known as transcutaneous VNS [tVNS] ). tVNS uses a portable device to send electrical stimulation through the skin to activate the vagus nerve. Although tVNS is still experimental, the approach may offer advantages over surgical VNS, such as greater accessibility and affordability, while avoiding surgical complications.

VNS: Why it’s done

VNS was initially developed as a treatment for epilepsy. Research using brain scans showed that the procedure also affected areas of the brain involved in mood regulation, with favorable effects on depression symptoms.

In 2005, the FDA approved surgical VNS for depression  when the following conditions are met:

• The patient is 18 years of age and older.
• The depression has lasted 2 or more years.
• The depression is severe or recurrent.
• The depression has not eased after trying at least four other treatments.

Despite FDA approval for depression, VNS is not intended as a first-line treatment and remains infrequently used. The results of studies examining its effectiveness for depression have been mixed. Whereas a review of clinical trials  of VNS for treatment-resistant depression found a sustained reduction in depression symptoms and enhanced quality of life, other studies  did not report meaningful improvements.

Although noninvasive forms of VNS have also shown antidepressant effects , tVNS is not authorized by the FDA as a treatment for depression. However, a portable VNS device has been cleared by the FDA to treat post-traumatic stress disorder (PTSD)  under a Breakthrough Device Designation, given to medical devices with preliminary evidence of clinical effectiveness compared to other available treatments. Research is ongoing to test the efficacy and safety of tVNS for depression, PTSD, and other mental disorders.

VNS: How it works

VNS is traditionally a surgical procedure.

• A device about the size of a stopwatch called a pulse generator is implanted in the upper left side of the chest while the patient is under anesthesia.
• Connected to the pulse generator is an electrical lead wire, which is then connected from the generator to the left vagus nerve.
• Typically, 30-second electrical pulses are sent every five minutes from the generator to the vagus nerve. The duration and frequency of the pulses may vary depending on how the generator is programmed.
• The vagus nerve, in turn, delivers those electrical signals to the brain.

The pulse generator, which operates continuously, is powered by a battery that lasts around 10 years, after which it must be replaced. Patients usually do not feel pain or discomfort as the device operates.

It may be several months before a patient notices any benefits, and not all patients respond to VNS. Some patients have no improvement in symptoms, and some may get worse.

The device can be temporarily deactivated by placing a magnet over the chest where the generator is implanted. A patient may want to deactivate the device if side effects become intolerable or before engaging in strenuous activity or exercise because it can interfere with breathing. The device reactivates when the magnet is removed.

Noninvasive forms of VNS consist of a device worn around the neck or ears or a handheld device. There are many questions about the most effective stimulation sites, parameters, and protocols for tVNS, and research is ongoing to determine the optimal conditions to achieve the greatest clinical benefits.

VNS: Side effects

VNS is not without risk. There may be complications, such as infection or pain from the implant surgery, or the device may come loose, move around, or malfunction, all of which can require additional surgery to correct.

Other potential side effects include the following:

• Discomfort or tingling in the area where the device is implanted
• Voice changes or hoarseness
• Cough or sore throat
• Neck pain or headaches
• Breathing problems, especially during exercise
• Difficulty swallowing
• Nausea or vomiting

If cleared by the FDA, tVNS devices may help overcome some of these surgical issues. Nonetheless, mild side effects of tVNS have been reported, including:

• Tingling, pain, or itchiness around the stimulation site
• Nausea or vomiting
• Dizziness

The long-term side effects of all forms of VNS are unknown.

Experimental therapies

Other brain stimulation therapies are actively being explored for specific mental disorders. The following therapies are still considered experimental and have not yet been authorized by the FDA to treat mental disorders.

What is magnetic seizure therapy?

Magnetic seizure therapy (MST) is a noninvasive procedure that uses high-powered magnetic stimulation to induce seizures. The seizures are targeted to a specific site in the brain.

In the United States, MST is available only as part of a clinical trial or research study. NIMH has information for people interested in joining a clinical trial of MST or another brain stimulation therapy.

MST: How it works

MST combines aspects of both ECT and rTMS. Like rTMS, MST uses magnetic pulses to stimulate a specific brain site. The pulses are given at a higher intensity and frequency than in rTMS to induce a seizure. Like in ECT, the patient is anesthetized and given a muscle relaxant to prevent movement during the procedure. The goal is to retain the effectiveness of ECT while reducing the risk of cognitive side effects.

During the procedure:

• An electromagnetic coil is held against the head, typically targeting the brain’s prefrontal area.
• Rapidly alternating strong magnetic pulses pass through the coil into the brain to induce a seizure. Anesthesia is used to ensure that the patient does not experience pain or feel the electrical pulses.
• The magnetic dosage is individualized for each patient by finding the patient-specific seizure threshold.

There is not agreement on MST’s optimal dosing, coil size, and stimulation site, and researchers are actively conducting studies to determine those specifications.

MST: Why it’s done

Introduced in 2001, MST is currently in the early stages of investigation and clinical use for treating mental disorders. A review of randomized clinical trials  examining MST for treatment-resistant depression showed promising results. However, more confirmatory evidence is needed to draw conclusions about MST’s effectiveness in treating depression and other mental disorders.

MST: Side effects

Like ECT, MST carries the risk of side effects caused by anesthesia and the induction of a seizure. These side effects can include the following:

• Headaches or scalp pain
• Dizziness
• Nausea or vomiting
• Muscle aches or fatigue

A systematic review and meta-analysis  found that MST produced fewer memory problems and other cognitive side effects and caused less confusion and shorter seizures compared to ECT.

What is deep brain stimulation?

Deep brain stimulation (DBS) is a surgical procedure that uses electricity to directly stimulate sites in the brain.

DBS can be used to treat severe OCD or depression in patients who have not responded to other treatments. It is available for other mental disorders only as part of a clinical trial.

DBS: How it works

DBS works by sending electrical pulses to specific brain areas. It requires surgery to implant electrodes in the brain. The specific brain area depends on the disorder being treated. For depression, the brain area was initially the subgenual anterior cingulate cortex, which can be overactive in depression and other mood disorders, and now includes several brain areas. For OCD, the brain area is usually the ventral capsule/ventral striatum or the bed nucleus of the stria terminalis.

Prior to the procedure, scans of the brain are taken using MRI, which the surgeon uses as a guide to determine where to place the electrodes during surgery.

Once a patient is ready for surgery:

• The head is numbed with a local anesthetic so the patient does not feel pain.
• The surgeon drills one or two small holes into the patient’s head; threads a thin insulated wire, usually a pair of wires, through the hole(s) and into the brain; and places electrodes into a specific brain area.
• The patient is awake while the electrodes are implanted to provide feedback on their placement but does not feel pain because the head is numbed and the brain itself does not register pain.
• After the electrodes are implanted, the patient is put under general anesthesia.
• The electrodes are attached to wires that run inside the body from the head, through the neck and shoulder, and down to the chest, where a small battery-operated generator (about the size of a pacemaker) is implanted. The pulse generator is placed under the skin in the upper chest. Whereas early DBS models used two pulse generators, one wired to each of the two implanted electrodes, most newer models use a single pulse generator to stimulate both electrodes.
• From the pulse generator, electrical pulses are delivered through the wires to the electrodes in the brain. Stimulation is applied continuously, and its frequency and level are customized to each patient. Although it is unclear exactly how DBS works to reduce symptoms, researchers believe that the pulses help “reset” the malfunctioning area of the brain so that it works normally again.

After the procedure, the patient may be given a device-based tool (like a hand-held controller or smart phone app) to help them monitor and manage their symptoms at home or provide feedback to their clinical care team.

DBS: Why it’s done

DBS was first developed to treat movement disorders , including tremor and Parkinson’s disease.

The FDA has since cleared DBS for severe OCD under a Humanitarian Device Exemption , which is a provision for rare diseases or conditions experienced by relatively few patients among whom it has been difficult to gather evidence to demonstrate effectiveness. However, there is still much to be learned about optimizing DBS treatment. Although a systematic review  found that DBS improves OCD symptoms, other review articles  have called for more confirmatory evidence before drawing conclusions about its effectiveness.

Similarly, DBS received Breakthrough Device Designation from the FDA in 2022  to investigate its use for treatment-resistant depression. A systematic review and meta-analysis  showed favorable effects of DBS in treating depression symptoms. Nonetheless, it remains an experimental treatment for depression until more data from high-quality studies are available.

DBS: Side effects

DBS carries risks associated with any brain surgery. For example, the procedure may lead to the following:

• Bleeding in the brain or stroke
• Device-related discomfort, pain, or infection around the incision
• Infection near the incision site
• Headaches
• Disorientation or confusion
• Cognitive impairment
• Lightheadedness, dizziness, nausea, or vomiting
• Trouble sleeping, agitation, or restlessness

Because the procedure is still being studied, other side effects not yet identified are possible. Long-term benefits and side effects are unknown.

Are there other types of brain stimulation therapy?

Other types of brain stimulation therapy are in development. Most are used in combination with other therapies or treatments to optimize clinical outcomes.

One emerging therapy that shows promise for treating mental disorders is trigeminal nerve stimulation (TNS) . The FDA approved TNS to treat attention-deficit/hyperactivity disorder (ADHD)  in children, but it has not yet been approved to treat other conditions or for adults.

Other noninvasive brain stimulation therapies include, but are not limited to, the following:

• Transcranial random noise stimulation (tRNS)
• Transcranial direct current stimulation (tDCS)
• Transcranial alternating current stimulation (tACS)
• Transcranial ultrasound stimulation (TUS)

The Neuromodulation and Neurostimulation Program and Multimodal Neurotherapeutics Program at NIMH support researchers as they develop new therapies and refine existing therapies to treat mental disorders and conditions.

Mental Health Association in New York State (MHANYS) has additional resources that can be accessed through its main website. These resources include links to advocacy and policy work, school-based programs, mental health wellness training programs and more.

MHANYS
mhanys.org

Advocacy and Policy
mhanys.org/advocacy-policy

Mental Health Community Partners
mhcommunitypartners.org

CarePath™
mhanys.org/carepath

SMHRT: Family Education
https://www.mentalhealthednys.org/family-education-webinar-series/

Data Source
National Institute of Mental Health: Mental Health Information Health Topics www.nimh.nih.gov/health/topics